Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season

Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season

Safety surveillance is required for each season’s influenza vaccines to rapidly detect and evaluate potential new safety concerns before the peak period of immunization. Here we report the results of an enhanced passive safety surveillance for a trivalent split-virion inactivated influenza vaccine (...

Full description

Bibliographic Details
Main Authors: Sonja Gandhi-Banga, Anne-Laure Chabanon, Cecile Eymin, Timothy Caroe, Karina Butler, Annick Moureau
Format: Article
Language:English
Published: Taylor & Francis Group 2019-09-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
influenza vaccines
vaccination
safety
safety surveillance
seasonal influenza
adverse reaction
adverse event
reactogenicity
immunization
Online Access:http://dx.doi.org/10.1080/21645515.2019.1581538

Internet

http://dx.doi.org/10.1080/21645515.2019.1581538

Similar Items